Document Detail


The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.
MedLine Citation:
PMID:  2775304     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The kinetics of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in rat and human liver microsomes have been compared. Quinidine is a potent inhibitor of debrisoquine 4-hydroxylase activity of human liver (IC50: 3.6 microM). However, its stereoisomer, quinine, is some 60 times less potent (IC50:223 microM). Both compounds are able to inhibit greater than 95% of 4-hydroxylase activity. In rat liver microsomes quinine is approximately 50 times more potent an inhibitor (IC50:2.4 microM) than quinidine (IC50:137 microM). Again, 4-hydroxylase activity is inhibited by greater than 95%. Inhibition of debrisoquine 4-hydroxylase activity by both quinine and quinidine in human and rat liver is competitive. Values of Ki for quinidine in human and rat were 0.6 microM and 50 microM, whereas with quinidine the Ki values were 13 microM and 1.7 microM, respectively. The data in this paper are consistent with 4-hydroxylation of debrisoquine in both rat and human liver catalysed by a specific form of cytochrome P-450. Although both quinidine and quinine are competitive inhibitors of debrisoquine 4-hydroxylase activity in rat and man, their potency is reversed. This suggests that the nature of the active site of cytochrome P-450dbl differs between the two species, and indicates that data on the specificity of this isoenzyme in the rat should be extrapolated to man with extreme caution.
Authors:
S Kobayashi; S Murray; D Watson; D Sesardic; D S Davies; A R Boobis
Related Documents :
1281274 - Rat pulmonary microsomal cytochrome p-450 enzymes involved in the activation of procarc...
8269614 - Increased cyp1a2 content and capacity to activate glu-p-1 and trp-p-2 in liver microsom...
9034244 - Evolutionary significance of vitamin c biosynthesis in terrestrial vertebrates.
6708934 - Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cy...
8654204 - In vitro hepatic metabolism of abt-418 in chimpanzee (pan troglodytes). a unique patter...
7674834 - Cytotoxic effects of postharvest fungicides, ortho-phenylphenol, thiabendazole and imaz...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biochemical pharmacology     Volume:  38     ISSN:  0006-2952     ISO Abbreviation:  Biochem. Pharmacol.     Publication Date:  1989 Sep 
Date Detail:
Created Date:  1989-09-27     Completed Date:  1989-09-27     Revised Date:  2009-09-29    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  2795-9     Citation Subset:  IM    
Affiliation:
Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cytochrome P-450 CYP2D6
Cytochrome P-450 Enzyme System / antagonists & inhibitors*
Debrisoquin / metabolism
Humans
Liver / drug effects*,  enzymology
Male
Mixed Function Oxygenases / antagonists & inhibitors*
Quinidine / pharmacology*
Quinine / pharmacology*
Rats
Rats, Inbred Strains
Species Specificity
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
1131-64-2/Debrisoquin; 130-95-0/Quinine; 56-54-2/Quinidine; 9035-51-2/Cytochrome P-450 Enzyme System; EC 1.-/Mixed Function Oxygenases; EC 1.14.14.1/Cytochrome P-450 CYP2D6

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modulation of phosphorylase kinase activity by sphingolipids.
Next Document:  Ethanol potentiates serotonin stimulated inositol lipid metabolism in primary astroglial cell cultur...